Medigene AG

Medigene AG Firmenkenndaten im Überblick

Product Range

Medigene has a drug for the treatment of genital warts (HPV infection) on the German market (distributed by Taurus Pharma GmbH).

Key Research Areas Medigene AG

Medigene concentrates on the development of personalized T cell-based immunotherapies to target various types and stages of cancer with focus on haematological malignancies.

Among others, Medigene develops therapeutic vaccines.
(All data based on corporate information from member Medigene AG , as of: 10/2015)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download